Press Releases

 
Press Releases
  Date Title View
Aug 9, 2016
Conference Call Scheduled Today at 8:30 a.m. EDT LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the second quarter of 2016. "Concert has made significant progress with our pipeline of multiple ...
Aug 2, 2016
LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its second quarter 2016 financial results on Tuesday, August 9, 2016, before the U.S. financial markets open. The Company will host a conference call and webcast at 8:30 a.m. EDT to discus...
Jul 6, 2016
LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the Cantor Fitzgerald Healthcare Conference on Wednesday, July 13, 2016, at 2:30 p.m. EDT at Le Parker Meridien in New York City. A live w...
Jun 10, 2016
Findings Confirmed Superior Pharmacokinetic Profile Relative to Kalydeco LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today presented results from a Phase 1 multiple ascending dose trial of CTP-656, a next generation CFTR potentiator bein...
May 19, 2016
LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has initiated its Phase 1 clinical program for CTP-543, which is being developed for the treatment of alopecia areata, an autoimmune disease for which there are currently no approved treatments. CTP-5...
May 17, 2016
LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the following upcoming investor conferences: The UBS 2016 Global Healthcare Conference on May 24, 2016 at 8:00 a.m. EDT in N...
May 5, 2016
Conference Call Scheduled Today at 8:30 a.m. EDT LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the first quarter of 2016. "We are continuing to build a diverse pipeline based on our deuterium ...
May 4, 2016
Phase 1 to Begin Second Quarter of 2016 Conference Call Scheduled Tomorrow at 8:30 a.m. EDT for Company Update and First Quarter 2016 Financial Results LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced its next ...
Apr 28, 2016
Multiple Dose Data Continues to Support Once-Daily Dosing and Differentiated Metabolite Profile Data to be Presented at the European Cystic Fibrosis Conference in June 2016 LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) toda...
Apr 28, 2016
LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its first quarter 2016 financial results on Thursday, May 5, 2016, before the U.S. financial markets open. The Company will host a conference call and webcast at 8:30 a.m. EDT to discuss f...
FirstPrevious
2
...
NextLast
= add release to Briefcase